When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PCRX - FDA Decision Imminent On Heron's Pain Therapy Candidate
Pacira BioSciences Inc.
We think Heron (HRTX) has a very good chance of approval by the FDA by the April 30, 2019 due date for its non-opioid pain med HTX-011. This would be good for society in our fight against the opioid crisis. Furthermore, it could be rewarding for investors too, since this derisking event if the FDA approves HTX-011 should increase the value of HRTX. Just how rewarding, might depend on the exact label language approved by the FDA if the FDA approves HTX-011.
HTX-011 is a long-acting, extended-release formulation of the local anesthetic bupivacaine